MedinCell SA

21
Strong Sell
  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: FR0004065605
EUR
27.38
-1.34 (-4.67%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
MedinCell SA Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-20.00
-27.00
-35.00
-29.00
-22.00
-24.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
24.00
3.00
-3.00
-2.00
0.00
3.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
19.00
-13.00
-25.00
-22.00
-15.00
-13.00
Cash Flow from Investing Activities
-14.00
-1.00
1.00
0.00
-1.00
0.00
Cash Flow from Financing Activities
35.00
27.00
6.00
0.00
51.00
5.00
Net Cash Inflow / Outflow
39.00
12.00
-18.00
-22.00
34.00
-8.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in EUR Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of MedinCell SA
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(EUR)
Change(%)
Profit Before Tax
-20.586
-55.382
35.00
62.83%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
24.534
-10.632
34.00
330.76%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
19.161
-52.367
71.00
136.59%
Cash Flow from Investing Activities
-14.608
6.901
-20.00
-311.68%
Cash Flow from Financing Activities
35.026
6.07
29.00
477.03%
Net Cash Inflow / Outflow
39.579
-38.304
77.00
203.33%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
1.092
-1.00
-100.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'25
stock-summary

YoY Growth in year ended Mar 2025 is 241.75% vs 46.83% in Mar 2024

Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
19.16
-13.52
241.75%